Investment Pitch

Name: FSD Pharma signs binding LOI to acquire NASDAQ-listed Therapix Biosciences
Uploaded: 05/11/2022 22:48:54
Duration: 00:05:04
Description: Therapix is currently repurposing an FDA-approved cannabinoid for the treatment of central nervous system disorders, sleep disorders, pain management, mild cognitive impairment, traumatic brain injury and infectious diseases.

S1:E64 FSD Pharma signs binding LOI to acquire NASDAQ-listed Therapix Biosciences

fullscreen